US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 146.015
- -0.585-0.40%
Trading Oct 2 13:22 ET
8.73BMarket Cap-15305P/E (TTM)
147.910High144.880Low289.18KVolume146.470Open146.600Pre Close42.43MTurnover0.49%Turnover RatioLossP/E (Static)59.76MShares161.00052wk High-24.55P/B8.66BFloat Cap85.28552wk Low--Dividend TTM59.32MShs Float183.980Historical High--Div YieldTTM2.07%Amplitude11.920Historical Low146.717Avg Price1Lot Size
Ascendis Pharma A/S Key Stats
EPS
According to the latest financial report of Ascendis Pharma A/S, the latest earnings per share (TTM) for the company is -1.91. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: EUR
Quarterly
Loading...
FCF
Interested in knowing about Ascendis Pharma A/S's free cash flow? The latest report shows it as -101.78M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: EUR
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ascendis Pharma A/S shows that the company's current ratio is 0.74, indicating healthy liquidity.
Currency: EUR
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ascendis Pharma A/S, the quick ratio is 0.40, indicating that the company can meet its short-term debt obligations.
Currency: EUR
Quarterly
Loading...
ROE
Want to learn more about the financial health of Ascendis Pharma A/S? The latest ROE figure is -104.66%, indicating that the company has stable profitability.
Currency: EUR
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ascendis Pharma A/S, the total asset return on investment (ROA) is -14.02%.
Currency: EUR
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ascendis Pharma A/S's latest financial report to see how their gross margin is doing - currently at 68.15%.
Currency: EUR
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ascendis Pharma A/S, the net profit margin is -303.85%, which is a good sign for its profitability.
Currency: EUR
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data